Genflow Biosciences plc (LON:GENF – Get Free Report) traded down 13.3% on Monday. The company traded as low as GBX 1.79 and last traded at GBX 1.82. Approximately 12,734,846 shares were traded during trading, an increase of 452% from the average daily volume of 2,308,831 shares. The stock had previously closed at GBX 2.10.
Genflow Biosciences Stock Performance
The stock has a market capitalization of £10.31 million, a P/E ratio of -5.48 and a beta of 2.29. The business has a fifty day simple moving average of GBX 2.01 and a 200-day simple moving average of GBX 2.08.
Genflow Biosciences (LON:GENF – Get Free Report) last posted its quarterly earnings results on Tuesday, September 29th. The company reported GBX (0.08) earnings per share for the quarter. Genflow Biosciences had a negative net margin of 170.64% and a positive return on equity of 332.06%.
About Genflow Biosciences
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Further Reading
- Five stocks we like better than Genflow Biosciences
- A Manufacturing Surprise Could Be a Big Win for These 2 Companies
- What a $1 Billion Chip Deal Says About Amazon’s AI Ambitions
- 3 Stocks Benefiting From AI Demand Just Announced Major Buybacks
- Insiders Are Selling These 3 Stocks, Should You?
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
